- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03149172
Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials
The purpose of this pilot study is to conduct a interventional prospective clinical trial to evaluate the efficacy of three different xenografts for ridge preservation by comparing the quality of newly formed bone using histomorphometric and micro CT analysis.The three xenograft materials under investigation are Bio-Oss® (bovine derived xenograft), Equimatrix® (equine derived xenograft), and Endobon® (bovine derived xenograft). There are no prospective studies comparing the effectiveness of these three materials, Bio-Oss®, Endobon® and Equimatrix®, when placed in extraction sockets.
Participants will be recruited from patients in the TUSDM clinics that require extraction of single rooted non-molar tooth and are treatment planned to receive dental implants in the future. Participants will be randomized to receive one of the three xenograft materials after tooth extraction. The percentage of newly formed bone and bone density will be compared between the three materials 4-6 months after ridge preservation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a pilot prospective clinical trial in which histological and micro CT analysis will be utilized to compare between Endobon®, Equimatrix®, and Bio-Oss®.
Primary aim: Compare the percentage of newly formed bone between Equimatrix®, Bio-Oss® and Endobon®.
The investigators hypothesize that the mean percentage of newly formed bone from Equimatrix® will be higher than Bio-Oss® and/or Endobon®.
Secondary aim: Compare the bone density between Equimatrix®, Bio-Oss® and Endobon®.
The investigators hypothesize that the bone density from Equimatrix® will be higher than Bio-Oss® and/or Endobon®.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts University School of Dental Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Non-restorable single rooted tooth in anterior or premolar region
- Patient previously treatment planned for implant procedure and implant restoration.
- > 10 mm from maxillary sinus or inferior alveolar canal (IAC)
- Intact buccal bone (only minor dehiscence or fenestrations (approximately < 50% of socket depth) can be accepted
- Non-smokers.
- Patients treatment planned for extraction and ridge preservation at Tufts University School of Dental Medicine.
Exclusion Criteria:
- Poor oral hygiene (plaque index>30%).
Systemic diseases that affect bone metabolism:
i. Osteoporosis ii. Osteomalacia iii. Hyperthyroidism iv. Hyperparathyroidism v. Paget's disease
Inflammatory and autoimmune diseases of the oral cavity (severe bone loss) (self-report):
i. Severe chronic periodontitis ii. Aggressive periodontitis iii. Necrotizing ulcerative periodontitis iv. Crohn's disease v. Multiple sclerosis vi. Rheumatoid arthritis vii. Systemic lupus erythematosus
- History of radiation to the head and neck, and /or chemotherapy.
- Current corticosteroid therapy.
- History of IV Bisphosphonates therapy or >3 years of oral intake.
- Infectious diseases such as HIV, tuberculosis, Hepatitis (self-report).
- Known allergy to research related materials.
- Self-reported pregnancy or lactation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Equimatrix®
Equimatrix® + Mucograft or alternatives
|
Ridge preservation bone grafting after tooth extraction
|
EXPERIMENTAL: Bio-Oss®
Bio-Oss® + Mucograft or alternatives
|
Ridge preservation bone grafting after tooth extraction
|
EXPERIMENTAL: Endobon®
Endobon® + Mucograft or alternatives
|
Ridge preservation bone grafting after tooth extraction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent New Bone Formation
Time Frame: 4-6 months after ridge preservation surgery
|
Histomorphometric determination of % new bone formation
|
4-6 months after ridge preservation surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone Density
Time Frame: 4-6 months after ridge preservation surgery
|
Measured by Micro CT Scanning
|
4-6 months after ridge preservation surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yong Hur, DDS, DMD, MS, Tufts University School of Dental Medicine
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #10963
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Bone Loss
-
Alexandria UniversityLehigh UniversityCompletedBone Loss | Horizontal Alveolar Bone Loss | Vertical Alveolar Bone LossEgypt
-
Pontificia Universidade Católica do Rio Grande...KU Leuven; ITI International Team for Implantology, Switzerland; Rio Grande do...Not yet recruitingAlveolar Bone Loss | Bone Loss, Alveolar | Grafting Bone | Alveolar Bone Atrophy | Bone Loss, OsteoclasticBrazil
-
Universidad de MurciaUnknownTooth Loss | Bone Loss, Alveolar | Bone Atrophy, AlveolarSpain
-
Università degli Studi di FerraraAzienda USL FerraraRecruitingBone Loss, Alveolar | Dehiscence | Alveolar Ridge EnlargementItaly
-
Postgraduate Institute of Dental Sciences RohtakNot yet recruitingBone Loss, AlveolarIndia
-
University of MichiganActive, not recruiting
-
Rio de Janeiro State UniversityCompleted
-
Semmelweis UniversityPurgo Biologics Inc.; FORM-LabCompletedBone Augmentation | Bone Loss, AlveolarHungary
-
Esraa Salem KamalRecruiting
-
Cairo UniversityRecruiting
Clinical Trials on Equimatrix®
-
Loma Linda UniversityAmerican Regent, Inc.CompletedInadequate Bone Height in Maxillary Posterior AreaUnited States
-
Dong-A ST Co., Ltd.CompletedFunctional DyspepsiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Galderma R&DCompletedAtopic DermatitisPhilippines, China
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Diphtheria | PolioUnited States
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownFunctional DyspepsiaKorea, Republic of
-
Amir AzarpazhoohInstitut Straumann AGCompletedPeriodontal Inflammation | Crown LengtheningCanada
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic Obstructive (COPD)Argentina
-
GuerbetCompletedPrimary Brain TumorColombia, Korea, Republic of, United States, Mexico